| 000 | 01291 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512020608.0 | ||
| 264 | 0 | _c19891106 | |
| 008 | 198911s 0 0 eng d | ||
| 022 | _a0730-0077 | ||
| 024 | 7 |
_a10.3109/10641968909035397 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMénard, J | |
| 245 | 0 | 0 |
_aHypertension costs: source, evolution and impact of cost-containment measures in various health-care systems. _h[electronic resource] |
| 260 |
_bClinical and experimental hypertension. Part A, Theory and practice _c1989 |
||
| 300 |
_a1149-69 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCost Control |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 |
_aDelivery of Health Care _xeconomics |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 |
_aDrug Prescriptions _xeconomics |
| 650 | 0 | 4 |
_aHealth Maintenance Organizations _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xeconomics |
| 650 | 0 | 4 |
_aOffice Visits _xeconomics |
| 650 | 0 | 4 | _aPatient Participation |
| 773 | 0 |
_tClinical and experimental hypertension. Part A, Theory and practice _gvol. 11 _gno. 5-6 _gp. 1149-69 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10641968909035397 _zAvailable from publisher's website |
| 999 |
_c2797189 _d2797189 |
||